ACKB

Ackermans & van Haaren is a company that most European equity investors have heard of but few have truly analyzed. Founded in 1876 and headquartered in Antwerp, it operates as a diversified holding company with controlling or significant stakes across marine engineering and contracting (primarily through DEME Group), private banking (through Delen Private Bank and Bank J. Van Breda), real estate and senior care, energy and resources, and a portfolio of growth capital investments. The company's market capitalization sits near EUR 9.2 billion, its 52-week range stretches from EUR 193.50 to EUR 300.20, and its share price as of the analysis date hovers around EUR 280.80. On the surface, this profile suggests a conglomerate. In practice, it is something more precise: a capital allocator whose returns are determined not by operational dominance in any single industry, but by the quality of its portfolio construction and the structural tailwinds behind its holdings.

The central analytical question for Ackermans & van Haaren is not whether any of its individual businesses define their respective markets. None of them do, at least not in the way that ASML defines lithography or that Euronext defines European exchange infrastructure. The question is whether the portfolio itself constitutes a structural advantage, and if so, what kind. This distinction matters because financial data providers classify ACKB variously as "Industrials" or "Financials," and neither label captures the company's actual function. It is neither a pure industrial operator nor a financial institution in the traditional sense. It is a permanent capital vehicle that deploys patient equity across long-duration assets, and its moat is the irreplicability of that specific portfolio at this specific moment in time.

Here is the L17X insight that standard financial analysis misses: Ackermans & van Haaren does not compete with anyone. It competes with the opportunity cost of capital. Its shareholders are not choosing between ACKB and another marine engineering company, or between ACKB and another private bank. They are choosing between ACKB's portfolio and assembling those exposures individually, and the holding discount that persists in the stock is the market's way of saying it believes it can do better on its own. The structural question is whether that discount is justified, shrinking, or a permanent feature of the vehicle's architecture. Net income jumped from EUR 399 million in 2023 to EUR 593 million in 2025, a 49% increase. EPS rose from EUR 12.13 to EUR 18.14 over the same period. These are not the characteristics of a stagnating conglomerate. They are the characteristics of a portfolio that is catching the right cycles.